| 标题 |
Octreotide fluid crystal provides sustained octreotide bioavailability and similar IGF1 suppression to that of octreotide LAR (Sandostatin LAR): randomized, open-label, Phase I, repeat-dose study in healthy volunteers |
| 网址 | |
| DOI |
10.1530/endoabs.35.p914
doi
|
| 其它 |
期刊:Endocrine Abstracts 作者:John G. Roberts; Margareta Linden; Camilla Cervin; Fredrik Tiberg 出版日期:2014-04-17 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)